𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Evaluation of Epstein-Barr virus antigen-based immunoassays for serological diagnosis of nasopharyngeal carcinoma

✍ Scribed by Julian W. Tang; Edda Rohwäder; Ida M.T. Chu; Raymond K.Y. Tsang; Katja Steinhagen; Apple C.M. Yeung; K.F. To; Paul K.S. Chan

Book ID
116631259
Publisher
Elsevier Science
Year
2007
Tongue
English
Weight
214 KB
Volume
40
Category
Article
ISSN
1386-6532

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Native early antigen of Epstein–Barr vir
Native early antigen of Epstein–Barr virus, a promising antigen for diagnosis of nasopharyngeal carcinoma
✍ Dewi K. Paramita; Jajah Fachiroh; Wayan T. Artama; Eric van Benthem; Sofia M. Ha 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 248 KB

## Abstract The Epstein–Barr virus (EBV) early antigen (EA) complex consists of multiple proteins with relevance for diagnosis of acute, chronic and malignant EBV related diseases, including nasopharyngeal carcinoma (NPC). In a recent study, it was found that the molecular diversity of EBV‐specific

IgA directed against early antigen of Ep
IgA directed against early antigen of Epstein-Barr virus is no specific marker for the diagnosis of nasopharyngeal carcinoma
✍ Gottfried Sigel; Monika Schillinger; Klaus Henninger; Georg Bauer 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 565 KB

## Abstract The aim of this study was to evaluate the significance and specificity of IgA directed against Epstein‐Barr virus (EBV)‐specific early antigens (EA) for the unequivocal diagnosis of nasopharyngeal carcinoma (NPC). Therefore, sera from patients with diseases other than NPC, selected on t

Detection of epstein-barr virus IgA/EA a
Detection of epstein-barr virus IgA/EA antibody for diagnosis of nasopharyngeal carcinoma by immunoautoradiography
✍ J. Zeng; C. H. Gong; M. G. Jan; Z. Fun; L. G. Zhang; H. Y. Li 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 French ⚖ 297 KB 👁 1 views

## Abstract An immunoautoradiographic method was used for the detection of EB virus lgA/EA antibody in sera from NPC patients and other control groups. Ninety‐six percent of NPC patients had IgA/EA antibody with a high titer of GMT. The positive rates of IgA/EA antibody in patients with malignant t